[
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-1",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#definitiongeneral548999",
    "clean_content": "Definition / general\n\n* Ameloblastic carcinoma is a rare primary odontogenic carcinoma of the jaw that exhibits ameloblastic differentiation, cytologic atypia, an increased number of mitotic figures, expansion of the basal layer and often punctate tumor necrosis* Most commonly arises within the bone of maxilla and mandible"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-2",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#essentialfeatures549000",
    "clean_content": "Essential features\n\n* Rare; represents ≤ 2% of all odontogenic tumors ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:191](15660091), [Int J Oral Maxillofac Surg 2007;36:20](17156974), [Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:151](30448231))* Essential criteria: exhibits a histological resemblance to ameloblastoma with increased cytologic atypia* Desirable criteria: intraosseous jaw tumor, tumor necrosis, associated ameloblastoma precursor, *BRAF* mutations in a subset* May show a combination of spindle cell, stellate, squamous, epithelioid or (limited) clear cell morphologies* Evidence of squamous differentiation is most reliably demonstrated by immunostaining for p40, p63 and CK5"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-3",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#terminology549001",
    "clean_content": "Terminology\n\n* Not recommended by WHO: malignant ameloblastoma, dedifferentiated ameloblastoma"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-4",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#icdcoding549002",
    "clean_content": "ICD coding\n\n* ICD-O: [9270/3](https://iris.who.int/bitstream/handle/10665/96612/9789241548496_eng.pdf?sequence=1#page=88) - ameloblastic carcinoma* ICD-11: [2B5J & XH4M89](https://icd.who.int/browse/2025-01/mms/en#1128819057%20%26%20435171869) - malignant miscellaneous tumors of bone or articular cartilage of other or unspecified sites & odontogenic tumor, malignant"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-5",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#epidemiology549003",
    "clean_content": "Epidemiology\n\n* Accounts for ≤ 2% of all odontogenic tumors ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:191](15660091), [Int J Oral Maxillofac Surg 2007;36:20](17156974), [Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:151](30448231))* Mean age: 46.1 years (median: 45 years; range: 2 - 93 years) ([J Oral Pathol Med 2024;53:174](38368851))* Sex predilection appears to vary between studies\n      + Slight female predominance ([J Oral Pathol Med 2024;53:174](38368851))+ Male predominance ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:799](17448710), [Oncol Lett 2014;8:914](25013517), [Eur Arch Otorhinolaryngol 2017;274:3803](28600599))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-6",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#sites549004",
    "clean_content": "Sites\n\n* More common in mandible than maxilla ([Eur Arch Otorhinolaryngol 2017;274:3803](28600599), [Oral Surg Oral Med Oral Pathol Oral Radiol 2016;121:e154](26768075), [Head Neck 2019;41:4191](31444935))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-7",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#pathophysiology549005",
    "clean_content": "Pathophysiology\n\n* *BRAF* p.V600E or *TP53* mutations have been reported in up to 40% of cases ([Tumour Biol 2015;36:5649](25854168), [Oral Oncol 2015;51:e77](26306423), [J Oral Pathol Med 2019;48:413](30889301), [Orphanet J Rare Dis 2020;15:316](33176823))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-8",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#etiology549006",
    "clean_content": "Etiology\n\n* Etiology is largely unknown* Majority of cases arise de novo* Some develop in longstanding untreated ameloblastoma or in locally recurrent ameloblastoma after treatment ([Oral Surg Oral Med Oral Pathol 1984;57:168](6366686), [Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:e146](24906942), [Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:716](11113817))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-9",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#clinicalfeatures549007",
    "clean_content": "Clinical features\n\n* Many cases present with rapidly progressive jaw swelling at the involved site, which may extend into the overlying mucosa ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:904](19800270), [Oral Surg Oral Med Oral Pathol Oral Radiol 2016;121:e154](26768075))* Symptoms such as nasal congestion, exophthalmos, toothache, paresthesia, toothache or tooth mobility are related to localized mass effect of the tumor in maxilla or mandible ([Eur Arch Otorhinolaryngol 2017;274:3803](28600599), [Head Neck 2019;41:4191](31444935))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-10",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#diagnosis549008",
    "clean_content": "Diagnosis\n\n* WHO blue book histological criteria for diagnosis of ameloblastic carcinoma\n  + Essential: exhibits a histological resemblance to ameloblastoma with increased cytologic atypia+ Desirable: an intraosseous jaw tumor, tumor necrosis, associated ameloblastoma precursor, *BRAF* mutations in a subset"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-11",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#laboratory549009",
    "clean_content": "Laboratory\n\n* Occasionally associated with hypercalcemia of malignancy ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:716](11113817))* In hypercalcemia of malignancy, laboratory abnormalities may include\n    + Elevated total and ionized calcium+ Suppressed parathyroid hormone (PTH) levels+ Normal or low 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels+ Increased alkaline phosphatase levels"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-12",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#radiologydescription549010",
    "clean_content": "Radiology description\n\n* Contrast enhanced computed tomography (CT) shows an expansile, largely hypodense lytic intraosseous jaw lesion with poorly defined margins as well as medullary and cortical bone destruction ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:904](19800270))* Commonly exhibits extension into soft tissues; magnetic resonance imaging (MRI) may help delineate ([J Clin Imaging Sci 2022;12:58](36601607))* Moderate fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) CT helps detect metastasis ([Dentomaxillofac Radiol 2010;39:449](20841465))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-13",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#radiologyimages549011",
    "clean_content": "Radiology images\n\nContributed by Kelly Magliocca, D.D.S., M.P.H.  \n\n[![Maxillary tumor on CT](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca01.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca01.jpg)\n\nMaxillary tumor on CT\n\n[![Mandibular tumor on CT](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca02.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca02.jpg)\n\nMandibular tumor on CT\n\n[![Mandibular tumor axial CT](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca03.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca03.jpg)\n\nMandibular tumor axial CT\n\n  \n  \nImages hosted on other servers:  \n\n[![Orthopantomogram](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih01.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573059/figure/F2/)\n\nOrthopantomogram\n\n[![Lucent lesion](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih02.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492487/figure/f1-amjcaserep-16-415/)\n\nLucent lesion\n\n[![Axial noncontrast CT](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih03.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520182/figure/dmf-39-449-g001/)\n\nAxial noncontrast CT\n\n[![Axial MRI](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih04.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520182/figure/dmf-39-449-g002/)\n\nAxial MRI"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-14",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#prognosticfactors549012",
    "clean_content": "Prognostic factors\n\n* Ameloblastic carcinoma is rare and the paucity of cases not only precludes an accepted pathologic staging paradigm but also undermines assessment of most prognostic factors; some investigators have attempted to understand the importance of some factors below (see associated references)* Points to consider in assessment of prognosis\n    + Stage: no accepted staging paradigm for odontogenic malignancies+ Age: disease spans a broad age range+ Primary anatomic location: mandible versus maxilla+ Tumor size+ Extension beyond bone into soft tissues+ Histological variables\n                - Presence / absence of benign precursor ameloblastoma ([Oral Surg Oral Med Oral Pathol 1984;57:168](6366686), [J Oral Maxillofac Surg 2007;65:777](17368379))- Histopathological patterns ([Oral Oncol 2018;77:118](29362117))- Tumor necrosis- Mitotic rate- Perineural or lymphovascular invasion- Margin status (note: without an R0 initial resection, there is no disease free interval)+ Presence of specific gene alterations+ Variability in treatment\n                    - Use of surgery alone- Surgery in combination with adjuvant radiation therapy or proton therapy- Use of standard chemotherapy versus targeted therapy* Local recurrence: up to 40% of cases ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:904](19800270), [Oncol Lett 2015;9:459](25436009))* Regional metastases to cervical nodes occur in up to 13% of patients ([Eur Arch Otorhinolaryngol 2017;274:3803](28600599), [Pol J Pathol 2018;69:243](30509051), [Orphanet J Rare Dis 2020;15:316](33176823))* Distant metastasis develops in 33% of cases, most commonly in the lung, followed by the brain, liver and bone ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:e17](17942338), [Eur Arch Otorhinolaryngol 2017;274:3803](28600599))* 5 year overall survival rate is 70% ([Orphanet J Rare Dis 2020;15:316](33176823), [Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:904](19800270))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-15",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#casereports549013",
    "clean_content": "Case reports\n\n* 31 year old man with headache and vision loss ([J Clin Imaging Sci 2022;12:58](36601607))* 61 year old woman with neck pain and right arm weakness ([Neurosurgery 2021;88:E537](33611519))* 68 year old man with a maxillary mass ([Int J Surg Pathol 2023;31:442](35668625))* 72 year old woman with mandibular pain ([Maxillofac Plast Reconstr Surg 2023;45:17](37101080))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-16",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#treatment549014",
    "clean_content": "Treatment\n\n* Primary treatment is heterogeneous, ranging from surgery alone to a combination of adjuvant therapies, including radiation therapy, traditional chemotherapy or targeted therapy ([Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:e56](30393089), [Eur Arch Otorhinolaryngol 2016;273:3293](26796877))\n  + Surgery: radical surgical resection is treatment of choice+ Radiation therapy: no established protocol+ Targeted therapy: BRAF or ALK inhibitor, depending on molecular findings ([Eur Arch Otorhinolaryngol 2016;273:3293](26796877))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-17",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Clinical images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#clinicalimages549015",
    "clean_content": "Clinical images\n\nImages hosted on other servers:  \n\n[![Erythematous growth](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinomapubmed01.jpg)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10133431/figure/Fig1/)\n\nErythematous growth\n\n[![Proliferative growth](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinomapubmed02.jpg)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10581286/figure/F2/)\n\nProliferative growth\n\n[![Extraoral swelling](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih05.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211248/figure/F1/)\n\nExtraoral swelling\n\n[![Pus discharge](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih06.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573059/figure/F1/)\n\nPus discharge\n\n[![Intraoral swelling](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih07.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244098/figure/Fig1/)\n\nIntraoral swelling"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-18",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#grossdescription549016",
    "clean_content": "Gross description\n\n* Cut surfaces reveal a solid mass with irregular borders and limited cystic change ([Dentomaxillofac Radiol 2010;39:449](20841465), [Oral Surg Oral Med Oral Pathol Oral Radiol 2016;121:e54](26238174))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-19",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#grossimages549017",
    "clean_content": "Gross images\n\nContributed by Kelly Magliocca, D.D.S., M.P.H.  \n\n[![Largely solid, tan-white tumor](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca04.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca04.jpg)\n\nLargely solid, tan-white tumor\n\n  \n  \nImages hosted on other servers:  \n\n[![Resected specimen](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih08.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211248/figure/F4/)\n\nResected specimen"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-20",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#microscopichistologicdescription549018",
    "clean_content": "Microscopic (histologic) description\n\n* Malignant tumor with varied morphology* Most commonly, tumor architecture is follicular, plexiform or solid nests of ameloblastoma-like epithelium* Peripheral palisading, nuclear reverse polarity and stellate reticulum must be evident at least focally* Tumor may comprise areas of squamous, spindle cell morphology or clear cell change ([Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:799](17448710), [Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:904](19800270), [Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:e146](24906942), [Histopathology 2016;69:687](27195964), [Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e113](30928327))* Tumor grows in undulating bulky cords, nests or sheets with pushing borders or angulated infiltrative nests at the advancing front* Tumor cells at the periphery of islands are often large with prominent nucleoli* Pleomorphism can be marked* Increased mitotic activity* Necrosis is often present (central tumor islands or single cell)* Extension into the mucosa does not distinguish benign ameloblastoma from carcinoma* Dispersed invasion and perineural infiltration are uncommon findings ([Arch Pathol Lab Med 2019;143:587](30500289), [Orphanet J Rare Dis 2020;15:316](33176823))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-21",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#microscopichistologicimages549019",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Kelly Magliocca, D.D.S., M.P.H.  \n\n[![Tumor necrosis](https://www.pathologyoutlines.com/imgau/mandiblemaxillawhoMagliocca1a.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillawhoMagliocca1a.jpg)\n \n[![Tumor necrosis](https://www.pathologyoutlines.com/imgau/mandiblemaxillawhoMagliocca1b.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillawhoMagliocca1b.jpg)\n\nTumor necrosis\n\n[![Mass merging with oral mucosa](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca05.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca05.jpg)\n\nMass merging with oral mucosa\n\n  \n\n[![Cyst-like spaces](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca06.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca06.jpg)\n\nCyst-like spaces\n\n[![Squamous / squamoid nests](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca07.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca07.jpg)\n\nSquamous / squamoid nests\n\n[![BRAF V600E](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca08.jpg)](https://www.pathologyoutlines.com/imgau/mandiblemaxillaameloblasticcarcinomamagliocca08.jpg)\n\nBRAF V600E IHC"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-22",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#cytologydescription549020",
    "clean_content": "Cytology description\n\n* Fine needle aspiration (FNA) biopsy may detect possible metastasis in known cases ([Dentomaxillofac Radiol 2010;39:449](20841465))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-23",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#cytologyimages549021",
    "clean_content": "Cytology images\n\nImages hosted on other servers:  \n\n[![Skull lesion, mandible primary](https://www.pathologyoutlines.com/thumb/mandiblemaxillaameloblasticcarcinoma_nih14.jpg)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3520182/figure/dmf-39-449-g005/)\n\nSkull lesion, mandible primary"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-24",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#positivestains549022",
    "clean_content": "Positive stains\n\n* [CK19](https://www.pathologyoutlines.com/topic/stainsck19.html), [CK5](https://www.pathologyoutlines.com/topic/stainsck5and6.html), [p63](https://www.pathologyoutlines.com/topic/stainsp63.html) ([Med Oral Patol Oral Cir Bucal 2017;22:e324](28390135))* [SOX2](https://www.pathologyoutlines.com/topic/stainssox2.html) can be positive but is variable and of limited utility in confirming a diagnosis of ameloblastic carcinoma ([F1000Res 2024;13:557](39082057), [Head Neck Pathol 2024;18:92](39365497))* [p53](https://www.pathologyoutlines.com/topic/stainsp53.html) overexpression in some but not all cases ([Histopathology 2016;69:687](27195964), [F1000Res 2024;13:557](39082057), [J Microsc Ultrastruct 2022;12:165](39507648))* [Ki67](https://www.pathologyoutlines.com/topic/stainski67.html) often elevated ([F1000Res 2024;13:557](39082057), [Head Neck Pathol 2024;18:92](39365497))* [BRAF V600E](https://www.pathologyoutlines.com/topic/stainsbraf.html) immunostain positive in a subset of cases ([J Oral Pathol Med 2021;50:85](32939809))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-25",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#negativestains549023",
    "clean_content": "Negative stains\n\n* [SOX10](https://www.pathologyoutlines.com/topic/stainssox10.html), [S100](https://www.pathologyoutlines.com/topic/stainss100.html) ([Case Rep Dent 2023;2023:8755637](36970563))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-26",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#molecularcytogeneticsdescription549024",
    "clean_content": "Molecular / cytogenetics description\n\n* *BRAF* is the most frequently mutated gene; the most frequent mutation is *BRAF* V600E ([Tumour Biol 2015;36:5649](25854168), [Orphanet J Rare Dis 2020;15:316](33176823))* Molecular abnormalities involving *ALK* or *TP53* may also occur but are less common ([Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:e146](24906942), [Oral Oncol 2022;132:105946](35759857))* *TERT* promoter mutations are uncommonly identified ([J Oral Pathol Med 2023;52:271](36169975))"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-27",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#samplepathologyreport549025",
    "clean_content": "Sample pathology report\n\n* Bone, left mandible and level 1 neck contents, radical resection:\n  + Ameloblastic carcinoma (8.2 cm) (see comment)+ Tumor necrosis: present+ Mitotic rate: 15 per 2 mm2+ Soft tissue invasion: present+ Perineural invasion: not identified+ Lymphovascular invasion: not identified+ Specimen surgical margin status\n                - All surgical margins negative for carcinoma- Carcinoma, 2 mm from nearest margin; posterior soft tissue+ Level I neck contents\n                  - 6 lymph nodes, negative for carcinoma (0/6)- Submandibular salivary gland with reactive changes+ Comment: At present, there is no universally accepted pathologic staging protocol for ameloblastic carcinoma, reflecting the rarity of this malignancy. In view of this limitation, a detailed summary of histopathologic features with potential relevance to clinical management is provided above."
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-28",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#differentialdiagnosis549026",
    "clean_content": "Differential diagnosis\n\n* [Ameloblastoma](https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblastoma.html):\n  + May share some of the same histological features (peripheral palisading, reverse polarization, stellate reticulum) but should not show features of malignancy (pleomorphism with hyperchromasia, atypical mitoses)+ Maxillary ameloblastoma can show high cellularity but is less commonly *BRAF* mutated* [Oral squamous cell carcinoma](https://www.pathologyoutlines.com/topic/oralcavityscc.html):\n    + Ideally exhibits surface dysplasia; mucosal precursor lesion+ May invade underlying bone but uncommonly is centered within the bone of the jaw+ Displays prominent intercellular bridges, a hallmark of squamous differentiation+ [BRAF V600E](https://www.pathologyoutlines.com/topic/stainsbraf.html) negative* [Clear cell odontogenic carcinoma](https://www.pathologyoutlines.com/topic/mandiblemaxillaclearcellodontogenic.html) ([Am J Surg Pathol 2013;37:1001](23715163)):\n      + Malignant epithelial odontogenic tumor composed primarily of nests and islands of clear cells+ May have focal peripheral palisading similar to ameloblastoma but typically lacks the cytologic atypia seen in ameloblastic carcinoma+ *EWSR* mutation"
  },
  {
    "id": "ameloblastic-carcinoma_49640_1750166800.txt-29",
    "source_document": "ameloblastic-carcinoma_49640_1750166800.txt",
    "parent": "mandible-amp-maxilla_81",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/mandiblemaxillaameloblasticcarcinoma.html#additionalreferences549027",
    "clean_content": "Additional references\n\n* [WHO Classification of Tumours Editorial Board: Head and Neck Tumours, 5th Edition, 2024](https://www.amazon.com/exec/obidos/ASIN/9283245148/pathologyoutl-20)"
  }
]